Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Short-Term Debt issuances (2020)

Sunshine Biopharma (SBFM) has disclosed Short-Term Debt issuances for 1 consecutive years, with $33607.0 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Short-Term Debt issuances changed N/A year-over-year to $33607.0, compared with a TTM value of $36607.0 through Dec 2021, changed N/A, and an annual FY2021 reading of $61500.0, up 51.45% over the prior year.
  • Short-Term Debt issuances was $33607.0 for Q4 2020 at Sunshine Biopharma, up from $3000.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $33607.0 in Q4 2020 and bottomed at $3000.0 in Q3 2020.